Investigators at Technion Israel Breakthrough—Potential Targeted Therapy Against Lung Adenocarcinoma

A team of medical researchers in Israel developed a novel strategy for a type of lung cancer with limited treatment options, the Israel Institute of Technology (Technion) said in a statement on Sunday.

In a study published in Nature Communications, the Technion researchers focused on lung adenocarcinoma (LUAD), a type of lung cancer often diagnosed at advanced stages with limited treatment options such as surgery and chemotherapy.